机构：[1]China Japan Friendship Hosp, Beijing, Peoples R China[2]Harbin Med Univ, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China[3]Kunming Med Univ, Affiliated Hosp 2, Kunming, Yunnan, Peoples R China[4]Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China首都医科大学附属北京同仁医院首都医科大学附属同仁医院[5]Anhui Prov Hosp, Hefei, Anhui, Peoples R China[6]Novo Nordisk AS, Soborg, Denmark[7]Novo Nordisk Pharmaceut, Princeton, NJ USA[8]Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
第一作者机构：[1]China Japan Friendship Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Yang Wenying,Li Qiang,Li Zhengfang,et al.A reduced risk of hypoglycaemia with insulin degludec vs. insulin glargine U100 in Asian insulin-naive patients with T2D[J].DIABETES RESEARCH AND CLINICAL PRACTICE.2016,120:S115-S115.
APA：
Yang, Wenying,Li, Qiang,Li, Zhengfang,Yang, Jin-Kui,Ye, Shandong...&Pan, Changyu.(2016).A reduced risk of hypoglycaemia with insulin degludec vs. insulin glargine U100 in Asian insulin-naive patients with T2D.DIABETES RESEARCH AND CLINICAL PRACTICE,120,
MLA：
Yang, Wenying,et al."A reduced risk of hypoglycaemia with insulin degludec vs. insulin glargine U100 in Asian insulin-naive patients with T2D".DIABETES RESEARCH AND CLINICAL PRACTICE 120.(2016):S115-S115
